Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas H Chakiryan

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Urology|December 24, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|September 9, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|April 30, 2026
Editorial CommentNicholas H Chakiryan
The Journal of Urology|February 4, 2026
Editorial CommentNicholas H Chakiryan
The Journal of Urology|May 14, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|September 8, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|December 10, 2024
Editorial CommentNicholas H Chakiryan
The New England Journal of Medicine|July 10, 2024
Adjuvant Pembrolizumab in Renal-Cell CarcinomaNicholas H Chakiryan, Marshall C Strother
The Journal of Urology|January 19, 2024
Editorial CommentWesley H Chou, Nicholas H Chakiryan
The Journal of Urology|July 2, 2024
Editorial CommentWesley H Chou, Nicholas H Chakiryan
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Urology|December 24, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|September 9, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|April 30, 2026
Editorial CommentNicholas H Chakiryan
The Journal of Urology|February 4, 2026
Editorial CommentNicholas H Chakiryan
The Journal of Urology|May 14, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|September 8, 2025
Editorial CommentNicholas H Chakiryan
The Journal of Urology|December 10, 2024
Editorial CommentNicholas H Chakiryan
The New England Journal of Medicine|July 10, 2024
Adjuvant Pembrolizumab in Renal-Cell CarcinomaNicholas H Chakiryan, Marshall C Strother
The Journal of Urology|January 19, 2024
Editorial CommentWesley H Chou, Nicholas H Chakiryan
The Journal of Urology|July 2, 2024
Editorial CommentWesley H Chou, Nicholas H Chakiryan
Pageof 6